Chinese General Practice ›› 2024, Vol. 27 ›› Issue (24): 2969-2975.DOI: 10.12114/j.issn.1007-9572.2024.0015
• Original Research • Previous Articles Next Articles
Received:
2023-12-20
Revised:
2024-03-15
Published:
2024-08-20
Online:
2024-05-08
Contact:
CHEN Yuefeng, CHEN Weiheng
通讯作者:
陈月峰, 陈卫衡
作者简介:
基金资助:
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0015
项目 | 发作期(n=867) | 缓解期(n=2 009) | 康复期(n=739) | C(K)值 | P值 | |||
---|---|---|---|---|---|---|---|---|
例数 | 百分比(%) | 例数 | 百分比(%) | 例数 | 百分比(%) | |||
性别 | 0.041 | 0.051 | ||||||
男 | 303 | 34.95 | 725 | 36.09 | 299 | 40.46 | ||
女 | 564 | 65.05 | 1 284 | 63.91 | 440 | 59.54 | ||
年龄(岁) | 0.019a | 0.180 | ||||||
40~49 | 35 | 4.04 | 149 | 7.42 | 48 | 6.50 | ||
50~59 | 162 | 18.69 | 186 | 9.26 | 76 | 10.28 | ||
60~69 | 173 | 19.95 | 325 | 16.17 | 227 | 30.72 | ||
70~79 | 226 | 26.07 | 823 | 40.97 | 192 | 25.98 | ||
≥80 | 271 | 31.26 | 526 | 26.18 | 196 | 26.52 | ||
BMI(kg/m2) | 0.235a | <0.001 | ||||||
<18.5 | 77 | 8.88 | 92 | 4.58 | 103 | 13.94 | ||
18.5~23.9 | 136 | 15.69 | 481 | 23.94 | 329 | 44.52 | ||
24.0~27.9 | 352 | 40.60 | 1 069 | 53.21 | 238 | 32.21 | ||
≥28.0 | 302 | 34.83 | 367 | 18.27 | 69 | 9.34 | ||
居住环境 | 0.005 | 0.963 | ||||||
高层且无电梯 | 530 | 61.13 | 1 206 | 60.03 | 465 | 62.92 | ||
低层或有电梯 | 337 | 38.87 | 803 | 39.97 | 274 | 37.08 | ||
膝关节创伤史 | 0.003 | 0.985 | ||||||
有 | 366 | 42.21 | 833 | 41.46 | 315 | 42.63 | ||
无 | 501 | 57.79 | 1 176 | 58.54 | 424 | 57.37 | ||
KOA家族史 | 0.002 | 0.990 | ||||||
有 | 401 | 46.25 | 908 | 45.20 | 332 | 44.93 | ||
无 | 466 | 53.75 | 1 101 | 54.80 | 407 | 55.07 | ||
骨质疏松病史 | 0.014 | 0.704 | ||||||
有 | 293 | 33.79 | 653 | 32.50 | 250 | 33.83 | ||
无 | 574 | 66.21 | 1 356 | 67.50 | 489 | 66.17 | ||
吸烟史(曾经吸烟) | 0.037 | 0.080 | ||||||
有 | 543 | 62.63 | 1 204 | 59.93 | 484 | 65.49 | ||
无 | 324 | 37.37 | 805 | 40.07 | 255 | 34.51 | ||
饮酒史(曾经饮酒) | 0.007 | 0.924 | ||||||
有 | 475 | 54.79 | 1 082 | 53.86 | 418 | 56.56 | ||
无 | 392 | 45.21 | 927 | 46.14 | 321 | 43.44 | ||
受教育水平 | 0.007a | 0.638 | ||||||
小学及以下 | 280 | 32.30 | 668 | 33.25 | 218 | 29.50 | ||
初中 | 321 | 37.02 | 748 | 37.23 | 271 | 36.67 | ||
高中 | 136 | 15.69 | 314 | 15.63 | 134 | 18.13 | ||
大学及以上 | 130 | 14.99 | 279 | 13.89 | 116 | 15.70 | ||
职业 | 0.019 | 0.526 | ||||||
体力劳动 | 583 | 67.24 | 1 386 | 68.99 | 513 | 69.42 | ||
非体力劳动 | 284 | 32.76 | 623 | 31.01 | 226 | 30.58 | ||
KL分级 | 0.406a | <0.001 | ||||||
Ⅰ级 | 31 | 3.58 | 121 | 6.02 | 172 | 23.27 | ||
Ⅱ级 | 134 | 15.46 | 1 015 | 50.52 | 450 | 60.89 | ||
Ⅲ级 | 392 | 45.21 | 723 | 35.99 | 29 | 3.92 | ||
Ⅳ级 | 310 | 35.76 | 150 | 7.47 | 88 | 11.91 |
Table 1 General information of patients with KOA in different clinical stages
项目 | 发作期(n=867) | 缓解期(n=2 009) | 康复期(n=739) | C(K)值 | P值 | |||
---|---|---|---|---|---|---|---|---|
例数 | 百分比(%) | 例数 | 百分比(%) | 例数 | 百分比(%) | |||
性别 | 0.041 | 0.051 | ||||||
男 | 303 | 34.95 | 725 | 36.09 | 299 | 40.46 | ||
女 | 564 | 65.05 | 1 284 | 63.91 | 440 | 59.54 | ||
年龄(岁) | 0.019a | 0.180 | ||||||
40~49 | 35 | 4.04 | 149 | 7.42 | 48 | 6.50 | ||
50~59 | 162 | 18.69 | 186 | 9.26 | 76 | 10.28 | ||
60~69 | 173 | 19.95 | 325 | 16.17 | 227 | 30.72 | ||
70~79 | 226 | 26.07 | 823 | 40.97 | 192 | 25.98 | ||
≥80 | 271 | 31.26 | 526 | 26.18 | 196 | 26.52 | ||
BMI(kg/m2) | 0.235a | <0.001 | ||||||
<18.5 | 77 | 8.88 | 92 | 4.58 | 103 | 13.94 | ||
18.5~23.9 | 136 | 15.69 | 481 | 23.94 | 329 | 44.52 | ||
24.0~27.9 | 352 | 40.60 | 1 069 | 53.21 | 238 | 32.21 | ||
≥28.0 | 302 | 34.83 | 367 | 18.27 | 69 | 9.34 | ||
居住环境 | 0.005 | 0.963 | ||||||
高层且无电梯 | 530 | 61.13 | 1 206 | 60.03 | 465 | 62.92 | ||
低层或有电梯 | 337 | 38.87 | 803 | 39.97 | 274 | 37.08 | ||
膝关节创伤史 | 0.003 | 0.985 | ||||||
有 | 366 | 42.21 | 833 | 41.46 | 315 | 42.63 | ||
无 | 501 | 57.79 | 1 176 | 58.54 | 424 | 57.37 | ||
KOA家族史 | 0.002 | 0.990 | ||||||
有 | 401 | 46.25 | 908 | 45.20 | 332 | 44.93 | ||
无 | 466 | 53.75 | 1 101 | 54.80 | 407 | 55.07 | ||
骨质疏松病史 | 0.014 | 0.704 | ||||||
有 | 293 | 33.79 | 653 | 32.50 | 250 | 33.83 | ||
无 | 574 | 66.21 | 1 356 | 67.50 | 489 | 66.17 | ||
吸烟史(曾经吸烟) | 0.037 | 0.080 | ||||||
有 | 543 | 62.63 | 1 204 | 59.93 | 484 | 65.49 | ||
无 | 324 | 37.37 | 805 | 40.07 | 255 | 34.51 | ||
饮酒史(曾经饮酒) | 0.007 | 0.924 | ||||||
有 | 475 | 54.79 | 1 082 | 53.86 | 418 | 56.56 | ||
无 | 392 | 45.21 | 927 | 46.14 | 321 | 43.44 | ||
受教育水平 | 0.007a | 0.638 | ||||||
小学及以下 | 280 | 32.30 | 668 | 33.25 | 218 | 29.50 | ||
初中 | 321 | 37.02 | 748 | 37.23 | 271 | 36.67 | ||
高中 | 136 | 15.69 | 314 | 15.63 | 134 | 18.13 | ||
大学及以上 | 130 | 14.99 | 279 | 13.89 | 116 | 15.70 | ||
职业 | 0.019 | 0.526 | ||||||
体力劳动 | 583 | 67.24 | 1 386 | 68.99 | 513 | 69.42 | ||
非体力劳动 | 284 | 32.76 | 623 | 31.01 | 226 | 30.58 | ||
KL分级 | 0.406a | <0.001 | ||||||
Ⅰ级 | 31 | 3.58 | 121 | 6.02 | 172 | 23.27 | ||
Ⅱ级 | 134 | 15.46 | 1 015 | 50.52 | 450 | 60.89 | ||
Ⅲ级 | 392 | 45.21 | 723 | 35.99 | 29 | 3.92 | ||
Ⅳ级 | 310 | 35.76 | 150 | 7.47 | 88 | 11.91 |
治疗方式 | 所有KOA患者(n=3 615) | 发作期(n=867) | 缓解期(n=2 009) | 康复期(n=739) | ||||
---|---|---|---|---|---|---|---|---|
例数 | 百分比(%) | 例数 | 百分比(%) | 例数 | 百分比(%) | 例数 | 百分比(%) | |
基础治疗 | ||||||||
健康教育 | 1 931 | 53.42 | 396 | 45.67 | 1 047 | 52.12 | 488 | 66.04 |
体质量管理 | 1 197 | 33.11 | 246 | 28.37 | 688 | 34.25 | 263 | 35.59 |
运动锻炼 | 971 | 26.86 | 44 | 5.07 | 681 | 33.90 | 246 | 33.29 |
传统功法 | 682 | 18.87 | 40 | 4.61 | 356 | 17.72 | 286 | 38.70 |
物理治疗 | 1 009 | 27.91 | 167 | 19.26 | 710 | 35.34 | 132 | 17.86 |
行动支持 | 353 | 9.76 | 124 | 14.30 | 168 | 8.36 | 61 | 8.25 |
药物治疗和中医外治法 | ||||||||
口服镇痛药物 | 333 | 9.21 | 158 | 18.22 | 159 | 7.91 | 16 | 2.17 |
口服缓解症状药物 | 681 | 18.84 | 62 | 7.15 | 480 | 23.89 | 139 | 18.81 |
抗焦虑药物 | 105 | 2.90 | 53 | 6.11 | 42 | 2.09 | 10 | 1.35 |
关节腔注射 | 313 | 8.66 | 114 | 13.15 | 145 | 7.22 | 54 | 7.31 |
口服中草药 | 468 | 12.95 | 194 | 22.38 | 251 | 12.49 | 23 | 3.11 |
口服中成药 | 1 073 | 29.68 | 475 | 54.79 | 523 | 26.03 | 75 | 10.15 |
外用西药 | 449 | 12.42 | 176 | 20.30 | 247 | 12.29 | 26 | 3.52 |
外用中草药 | 499 | 13.80 | 264 | 30.45 | 207 | 10.30 | 28 | 3.79 |
外用中成药 | 1 961 | 54.25 | 598 | 68.97 | 1 084 | 53.96 | 279 | 37.75 |
针刺 | 903 | 24.98 | 220 | 25.37 | 585 | 29.12 | 98 | 13.26 |
艾灸 | 417 | 11.54 | 70 | 8.07 | 293 | 14.58 | 54 | 7.31 |
针刀 | 399 | 11.04 | 71 | 8.19 | 285 | 14.19 | 43 | 5.82 |
拔罐 | 1 100 | 30.43 | 176 | 20.30 | 790 | 39.32 | 134 | 18.13 |
刺络拔罐 | 288 | 7.97 | 92 | 10.61 | 166 | 8.26 | 30 | 4.06 |
手法 | 536 | 14.83 | 68 | 7.84 | 398 | 19.81 | 70 | 9.47 |
Table 2 Current treatment status of KOA patients with different clinical stages
治疗方式 | 所有KOA患者(n=3 615) | 发作期(n=867) | 缓解期(n=2 009) | 康复期(n=739) | ||||
---|---|---|---|---|---|---|---|---|
例数 | 百分比(%) | 例数 | 百分比(%) | 例数 | 百分比(%) | 例数 | 百分比(%) | |
基础治疗 | ||||||||
健康教育 | 1 931 | 53.42 | 396 | 45.67 | 1 047 | 52.12 | 488 | 66.04 |
体质量管理 | 1 197 | 33.11 | 246 | 28.37 | 688 | 34.25 | 263 | 35.59 |
运动锻炼 | 971 | 26.86 | 44 | 5.07 | 681 | 33.90 | 246 | 33.29 |
传统功法 | 682 | 18.87 | 40 | 4.61 | 356 | 17.72 | 286 | 38.70 |
物理治疗 | 1 009 | 27.91 | 167 | 19.26 | 710 | 35.34 | 132 | 17.86 |
行动支持 | 353 | 9.76 | 124 | 14.30 | 168 | 8.36 | 61 | 8.25 |
药物治疗和中医外治法 | ||||||||
口服镇痛药物 | 333 | 9.21 | 158 | 18.22 | 159 | 7.91 | 16 | 2.17 |
口服缓解症状药物 | 681 | 18.84 | 62 | 7.15 | 480 | 23.89 | 139 | 18.81 |
抗焦虑药物 | 105 | 2.90 | 53 | 6.11 | 42 | 2.09 | 10 | 1.35 |
关节腔注射 | 313 | 8.66 | 114 | 13.15 | 145 | 7.22 | 54 | 7.31 |
口服中草药 | 468 | 12.95 | 194 | 22.38 | 251 | 12.49 | 23 | 3.11 |
口服中成药 | 1 073 | 29.68 | 475 | 54.79 | 523 | 26.03 | 75 | 10.15 |
外用西药 | 449 | 12.42 | 176 | 20.30 | 247 | 12.29 | 26 | 3.52 |
外用中草药 | 499 | 13.80 | 264 | 30.45 | 207 | 10.30 | 28 | 3.79 |
外用中成药 | 1 961 | 54.25 | 598 | 68.97 | 1 084 | 53.96 | 279 | 37.75 |
针刺 | 903 | 24.98 | 220 | 25.37 | 585 | 29.12 | 98 | 13.26 |
艾灸 | 417 | 11.54 | 70 | 8.07 | 293 | 14.58 | 54 | 7.31 |
针刀 | 399 | 11.04 | 71 | 8.19 | 285 | 14.19 | 43 | 5.82 |
拔罐 | 1 100 | 30.43 | 176 | 20.30 | 790 | 39.32 | 134 | 18.13 |
刺络拔罐 | 288 | 7.97 | 92 | 10.61 | 166 | 8.26 | 30 | 4.06 |
手法 | 536 | 14.83 | 68 | 7.84 | 398 | 19.81 | 70 | 9.47 |
治疗方式 | 所有KOA患者(n=3 615) | 发作期(n=867) | 缓解期(n=2 009) | 康复期(n=739) | ||||
---|---|---|---|---|---|---|---|---|
例数 | 百分比(%) | 例数 | 百分比(%) | 例数 | 百分比(%) | 例数 | 百分比(%) | |
1种 | 309 | 8.55 | 20 | 2.31 | 84 | 4.18 | 205 | 27.74 |
2~3种 | 1 618 | 44.76 | 293 | 33.79 | 976 | 48.58 | 349 | 47.23 |
4~5种 | 1 296 | 35.85 | 422 | 48.67 | 689 | 34.30 | 185 | 25.03 |
>5种 | 392 | 10.84 | 132 | 15.22 | 260 | 12.94 | 0 | 0 |
Table 3 Treatment types for patients with KOA in different clinical stages
治疗方式 | 所有KOA患者(n=3 615) | 发作期(n=867) | 缓解期(n=2 009) | 康复期(n=739) | ||||
---|---|---|---|---|---|---|---|---|
例数 | 百分比(%) | 例数 | 百分比(%) | 例数 | 百分比(%) | 例数 | 百分比(%) | |
1种 | 309 | 8.55 | 20 | 2.31 | 84 | 4.18 | 205 | 27.74 |
2~3种 | 1 618 | 44.76 | 293 | 33.79 | 976 | 48.58 | 349 | 47.23 |
4~5种 | 1 296 | 35.85 | 422 | 48.67 | 689 | 34.30 | 185 | 25.03 |
>5种 | 392 | 10.84 | 132 | 15.22 | 260 | 12.94 | 0 | 0 |
[1] |
|
[2] |
|
[3] |
|
[4] |
刘茜,张含之,邱梦思,等. 社区骨关节炎管理现状和策略的系统综述[J]. 中国全科医学,2022,25(25):3157-3164. DOI:10.12114/j.issn.1007-9572.2022.0137.
|
[5] |
|
[6] |
|
[7] |
陈卫衡. 膝骨关节炎中医诊疗指南(2020年版)[J]. 中医正骨,2020,32(10):1-14.
|
[8] |
中华医学会骨科学分会关节外科学组. 骨关节炎诊疗指南(2018年版)[J]. 中华骨科杂志,2018,38(12):705-715. DOI:10.3760/cma.j.issn.0253-2352.2018.12.001.
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
陈禺,阮世强,陈蝴蝶,等. 膝骨性关节炎影像评级与疼痛症状相关性[J]. 中国矫形外科杂志,2022,30(7):620-624. DOI:10.3977/j.issn.1005-8478.2022.07.09.
|
[14] |
中国中医药研究促进会骨科专业委员会,中国中西医结合学会骨伤科专业委员会关节工作委员会. 膝骨关节炎中医诊疗专家共识(2015年版)[J]. 中医正骨,2015,27(7):4-5.
|
[15] |
|
[16] |
李述文,李瑞涵,贾雁,等. 真实世界藤黄健骨片联合非甾体抗炎药治疗膝骨关节炎临床研究[J]. 中国实验方剂学杂志,2023,29(15):110-118. DOI:10.13422/j.cnki.syfjx.20230342.
|
[17] |
高帅,周峻,梁志,等. 基于真实世界的恒古骨伤愈合剂治疗638例膝骨关节炎患者临床特征及用药规律分析[J]. 中国中医药信息杂志,2023,30(10):157-162. DOI:10.19879/j.cnki.1005-5304.202211502.
|
[18] |
王瑛琦,徐晓君. 北京市老年人社区康复健康管理模式和路径的探讨[J]. 中国老年保健医学,2022,20(6):139-143. DOI:10.3969/j.issn.1672-2671.2022.06.033.
|
[19] |
李宗伟,蔡兰芳,苑荣,等. 分级诊疗背景下基层医疗卫生机构运行效率测评及影响因素研究[J]. 中国医院,2022,26(12):20-23. DOI:10.19660/j.issn.1671-0592.2022.12.06.
|
[20] |
王颖,牟墨涵,赵世超,等. 分级诊疗背景下山东省居民基层首诊意愿影响因素研究[J]. 医学与社会,2021,34(2):77-81. DOI:10.13723/j.yxysh.2021.02.016.
|
[21] |
刘茜,张含之,邱梦思,等. 社区骨关节炎管理现状和策略的系统综述[J]. 中国全科医学,2022,25(25):3157-3164. DOI:10.12114/j.issn.1007-9572.2022.0137.
|
[22] |
|
[23] |
|
[24] |
|
[25] |
《中成药治疗优势病种临床应用指南》标准化项目组. 中成药治疗膝骨关节炎临床应用指南(2020年)[J]. 中国中西医结合杂志,2021,41(5):522-533. DOI:10.7661/j.cjim.20210225.104.
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[1] | Eating Disorders Coordination Group of the Psychosomatic Medicine Society of the Chinese Medical Association, Eating Disorders Research Collaboration Group of the Psychiatric Medicine Society of the Chinese Medical Association, PENG Sufang, HE Qianqian, LIU Qiang, CHEN Yan, ZHANG Lan, LI Xueni, QIAO Huifen, KONG Qingmei, KUANG Guifang, CHEN Han, YU Yang, JIANG Jingjing, LIU Lanying, ZHANG Darong, LI Keqing, WANG Zhen, CHEN Jue. Chinese Expert Consensus on the Diagnosis and Treatment of Binge Eating Disorder [J]. Chinese General Practice, 2024, 27(24): 2941-2953. |
[2] | TAN Huiwen, LI Danting, YU Yerong. Interpretation of the 2022 ICCE/AME Position Statement for Clinical Practice in Pituitary Prolactinoma: Update on Clinical Characteristics and Points of Diagnosis and Treatment of Pituitary Prolactinoma [J]. Chinese General Practice, 2024, 27(06): 650-655. |
[3] | LIU Zhigang, LIU Shimeng, ZHENG Lyuyun, XUE Wenjing, CAO Chenchen, LIU Jing, CHEN Yingyao. Second-line Medication Preference in Patients with Type 2 Diabetes: a Study Based on a Discrete Choice Experiment [J]. Chinese General Practice, 2024, 27(01): 67-73. |
[4] | WANG Qiuqin, ZHANG Yutong, XU Yuchen, BAI Yamei, CHEN Hua, JIANG Rongrong, YAN Shuxia, WANG Qing, XU Guihua, XIE Ying, QIAO Chun, YANG Juan. Short-term Clinical Effect of Guasha Combined with Drug Therapy on Idiopathic Parkinson's Disease [J]. Chinese General Practice, 2023, 26(17): 2155-2161. |
[5] | Chinese Society of Osteoporosis and Bone Mineral Research. Guidelines for the Diagnosis and Treatment of Primary Osteoporosis (2022) [J]. Chinese General Practice, 2023, 26(14): 1671-1691. |
[6] | YAO Huijuan, YANG Yu, XU Ajing. Interpretation of Diabetes Management in Chronic Kidney Disease: a Consensus Report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO) [J]. Chinese General Practice, 2023, 26(12): 1415-1421. |
[7] | SONG Pingan, CHEN Xiaoliang, YAO Yuan, GAO Jin, YANG Yang, CUI Hongchun, ZHANG Yi. Efficacy and Safety of PD-1 Inhibitors Monotherapy for Elderly Patients with Advanced Non-small Cell Lung Cancer [J]. Chinese General Practice, 2023, 26(02): 241-247. |
[8] | Pengxiang ZHANG, Lin ZENG, Lu MENG, Qian HUANG, Gaoxiang WANG, Deliang LIU. New Research Progress of the Novel Target Drugs for the Treatment of Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2022, 25(20): 2551-2557. |
[9] | Ling LI, Huijuan ZHANG. Recent Developments in Pituitary-directed Medical Treatment for Cushing's Disease [J]. Chinese General Practice, 2022, 25(14): 1789-1794. |
[10] |
CHEN Xiaofeng, WANG Meng, LI Zhongyu, LI Jiajia.
Clinical Study of Venetoclax with Chemotherapy for Relapsed/Refractory Acute Myeloid Leukemia [J]. Chinese General Practice, 2022, 25(08): 957-962. |
[11] |
YANG Rongjun, SHI Yufang, WANG Qinghai.
Advances in Mechanism of Coexistence and Pharmaceutical Treatment of Chronic Heart Failure and Depression [J]. Chinese General Practice, 2022, 25(05): 625-630. |
[12] |
WU Xingwei, LIU Xinyu, LONG Enwu, TONG Rongsheng.
Research Progress of Machine Learning in Clinical Drug Therapy [J]. Chinese General Practice, 2022, 25(02): 254-258. |
[13] | LI Zhenghuan,ZHANG Xiaoyun,CHEN Yang,SONG Xueli,QIN Zhongming,LI Hong. Interpretation of the 2020 GOLD's Global Strategy for Prevention,Diagnosis and Management of COPD(Ⅰ):Pharmacological Treatment of Stable COPD [J]. Chinese General Practice, 2021, 24(8): 923-929. |
[14] | WU Xiaowei,YANG Yaofang,ZHU Jianping,ZHANG Li. Outpatient Use of Domperidone Tablets and the Contributive Role of Intelligent Knowledge Base [J]. Chinese General Practice, 2021, 24(7): 869-874. |
[15] | LIU Shuangxue, LI Yanhua. Advances in the Treatment of Genitourinary Syndrome of Menopause [J]. Chinese General Practice, 2021, 24(36): 4665-4670. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||